MiR-130b overexpressed in CD133+ tumor-initiating cells (TIC) of HCC enhances chemoresistance, tumorigenicity, and self-renewal via suppression of its downstream target gene, TP53INP1 [86]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.